Isolated human gastric glands from surgical specimens were preincubated in an oxygenated medium with placebo or 16,16 dimethyl prostaglandin E2 (dmPGE2) and incubated at 37°C in either medium alone, medium containing 4.43 mM indomethacin or medium containing 8% ethanol. We assessed the viability of gland cells with fast green exclusion, release of lactate dehydrogenase (LDH) into the medium, and ultrastructural damage by scanning and transmission electron microscopy. Both indomethacin and ethanol significantly reduced the viability of placebo-pretreated glands, increased LDH release into the medium, and produced prominent ultrastructural damage. DmPGE2 significantly reduced both indomethacin and ethanol-induced injury, increased the number of viable cells, reduced LDH release, and diminished the extent of ultrastructural damage. These studies indicate that PG protection of gastric mucosal cells has a direct cellular action that is not limited to replacement of depleted endogenous PGs. PG protection in our experiments did not depend on PG's previously described systemic actions, such as protection of the microvessels, preservation of the mucosal blood flow, or stimulation of bicarbonate and mucus secretion.
Introduction
Gastrointestinal mucosa is very active in the production of endogenous PGs from their precursors, dietary essential fatty acids (1) . Mucosal generation of PGs and their release into the gastric lumen upon vagal or hormonal stimulation (2) may play an important role in local control of various gastric mucosal functions and in maintaining mucosal integrity (3) (4) (5) . The discovery that aspirin and other nonsteroidal antiinflammatory drugs significantly inhibit formation of PGs (6) (7) (8) provided insight into the mechanisms of antiinflammatory action of nonsteroidal antiinflammatory drugs and their gastrointestinal side effects, which could result from mucosal PGs' deficiency.
When administered in vivo, PGs protect the gastric mucosa against necrosis produced by various noxious agents (3) (4) (5) (8) (9) (10) (11) (12) (13) (14) , including indomethacin (8) (9) (10) (11) (12) (13) , aspirin (12) , and ethanol (3) (4) (5) 14) . This PGs' action appears to be independent of their ability to inhibit gastric acid secretion, and is generally referred to as cytoprotection or mucosal protection (3-5, 9, 10) . Stimulation of mucus and bicarbonate secretion, maintenance of mucosal blood flow, preservation of cellular ion transport, and protection of the mucosal proliferative zone have been postulated as potential systemic mechanisms responsible for the protective action of PGs (3-5, 9, 10, 14) . While protection ofthe vascular endothelium (1 5) and maintenance of the mucosal blood flow (16) are well-documented components of PGs' protection, especially against ethanol injury, the possibility that PGs can directly interact with and protect the gastric mucosal cells in the absence of mucus, bicarbonate, blood flow, and other systemic factors has only been tested in the rat with inconclusive results (17) and has remained unexplored in man.
We used isolated human gastric glands to determine if PGs have a direct protective action on gastric mucosal cells. Be Results 2-h incubation of placebo-pretreated isolated human gastric glands with indomethacin resulted in a significant reduction of viability of gland cells assessed by fast green exclusion ( Fig. 1 ) and a significant increase of LDH release into the medium (Fig. 2) . Scanning EM, when compared with controls ( Fig. 3  A) , showed severe damage and disintegration of the glands, detachment of the cells, loss of cellular shape, and loss of microvilli (Fig. 3 B) . Transmission EM confirmed these findings and showed necrosis of numerous cells (Fig. 4 B) . Pretreatment with either 0.52-or 2.6-AM dose of dmPGE2 significantly reduced the extent of indomethacin-induced injury of gland cells as reflected by increased cell viability (Fig. 1) , decreased LDH release into the medium (Fig. 2) 1-h incubation of placebo-pretreated isolated human gastric glands with 8% ethanol produced significant reduction of cell viability (Table I ), significant increase in LDH release into the medium (Table I) , and severe morphologic injury documented by scanning and transmission EM (Figs. 5 B and 6 B) .
PG pretreatment significantly reduced the extent of ethanol-induced injury of gland cells, increasing cell viability (Table I) , decreasing LDH release into the medium (Table I) , and decreasing ultrastructural damage when compared with the placebo-pretreated group (Figs. 5 C and 6 C).
There was a strong positive linear correlation between cell death assessed by the inability to exclude fast green and LDH release into the medium for both indomethacin (r = 0. (26), and inhibition of cellular active transport of sodium (9) . Mechanisms ascribed to ethanol injury of gastric mucosa in vivo include surface epithelial exfoliation with loss of "barrier," transport, and electrical functions (14, 27) and hemorrhagic necrosis of deeper mucosal layers including the progenitor and glandular cells (14, 27) . Ethanol-induced damage to endothelial cells occurs within minutes ofexposure and results in microvascular stasis. This microvascular injury has been proposed to be an important mechanism responsible for deep mucosal necrosis after ethanol administration ( 15, 28) .
PGs protect the gastric mucosa against indomethacin-or ethanol-induced damage in vivo. While some of the morphologic, functional, and temporal features of PGs' mucosal protection in vivo have been characterized (3-5, 14-16, 27, 28), such studies have not ascertained whether this protection is predominantly mediated by systemic factors such as blood flow, hormonal or neural factors, or whether PGs' direct action on the gastric mucosal cells themselves is an important facet of mucosal protection.
By using isolated gastric glands in our experiments we excluded blood flow and extraglandular hormonal as well as neural factors; we therefore studied PGs' direct action on the cells. Our data clearly demonstrated that dmPGE2 exerts a direct protective action on the human gastric mucosal cells in the absence of systemic factors. Preincubation of the human gastric glands with dmPGE2 significantly reduced both indo- methacin-and ethanol-induced gastric gland cell necrosis, increased the number of viable cells, decreased LDH release into the medium, and reduced the extent of ultrastructural destruction detected by scanning and transmission EM. These findings indicate that dmPGE2 exerts a direct protective effect on the glandular cells themselves. Such action of PGs may be partly responsible for their protective action in vivo and perhaps for their prophylactic and therapeutic effects in clinical settings (5) . While reduction of indomethacin-induced damage to isolated human gastric glands by dmPGE2 could be due to replacement of depleted mucosal PGs, the protection by dmPGE2 against ethanol injury cannot be explained by such a simple mechanism, because ethanol does not inhibit PG synthesis (29) . Therefore, PG mucosal protection against injury must include the direct effects of PG on cell membranes or metabolism. The effect of dmPGE2 on the barrier function of the membrane, reflected by both preventing a dye from penetrating the cell and preventing efflux of LDH, may suggest that the cell membrane itself could be a major site of PGs' protective action.
The PG used in our experiment significantly reduced, but did not completely prevent, cell damage. One could ask whether a higher concentration of PG would have offered a greater degree of protection. We explored this question in our previous experiments in isolated rat gastric glands. We found that higher concentrations of dmPGE2 (13 and 26 ,M) offered a similar degree of protection as did 2.6 uM, against either indomethacin or ethanol injury. The higher dose of dmPGE2 (26 ,M) used in our present study did not furnish more protection against indomethacin injury than did 2.6 ,uM dmPGE2. These findings indicate that there is a threshold concentration of PG which offers cell protection. Once the protective threshold concentration is reached, higher concentrations of PG do not offer additional protection.
In this respect, our in vitro data are in agreement with the studies in vivo which showed that even at very high doses, dmPGE2 significantly reduced, but did not completely prevent, gastric mucosal damage (14) . Of several different PG (natural PGE,, PGE2, their synthetic analogues and PGI2) we studied in rats, 16,16 dmPGE2 had the most potent protective effect on the gastric mucosa. The limited availability of the human gastric surgical specimens narrowed our choice of PG to the most potent PG preparation, which has also been shown to protect the human gastric mucosa in vivo (30) .
The concentration of indomethacin used in our study was higher than the concentration used to inhibit PG synthesis (1, 8) . Since PG did not completely protect against injury even at higher concentrations, we propose that indomethacin has a direct cytotoxic effect which is entirely or partly independent of its known ability to inhibit PG synthesis. The loss of micro- villi and changes in cell shape observed after indomethacin or ethanol injury in placebo-pretreated glands suggest that the cell cytoskeleton may be one specific target for the toxic effect of these agents. Since cytoskeletal elements (actin filaments, microtubules, and intermediate filaments) and their associated proteins play an important role in supporting cell structure and shape (31) (32) (33) , and since indomethacin-or ethanol-induced injury involves changes in cell shape, loss of microvilli, and formation of membrane microblebs, it is reasonable to postulate that indomethacin and ethanol-induced cell injury are due in part to destruction or modification of cytoskeletal elements. Correspondingly, these elements may also be a site of PG-induced protection. This hypothesis must be explored in future studies designed specifically to answer these questions.
The concentrations of indomethacin and ethanol used in these studies were selected on the basis of our previous experiments with isolated rat gastric glands (unpublished data), which showed that these concentrations of indomethacin and ethanol reduced gland viability by > 50% within 1-2 h. In the present study we found that these concentrations of indomethacin and ethanol had similar toxic effects on isolated human gastric gland cells. In this context, it is interesting that in isolated rat gastric glands, lower concentrations of indomethacin (e.g., 8.8 and 44 ,M, sufficient to inhibit PG synthesis) produced cell swelling and partial gland cell separation but did not affect gastric gland cells viability and LDH release. These findings indicate that a short-term inhibition of PG synthesis does not cause toxic cell injury by indomethacin in our experimental model. This contention is also supported by the fact that alcohol does not inhibit synthesis of PG but produces acute toxic injury of gastric gland cells. These findings indicate that acute toxic injury of gastric gland cells may be independent of PG inhibition.
Abecassis et al. have recently demonstrated that dmPGE2 is able to prevent viral-induced damage to the liver in vivo and to cultured hepatocytes in vitro (34). These experiments indicate that PG can protect hepatocytes directly without systemic mediation, thereby suggesting that the direct protective action of PG is not limited to gastroduodenal cells only, but may be a more general phenomenon.
Finally, in this study we used the fast green exclusion test for assessing cell viability. This method has been used before only to assess the viability of neoplastic cells (20) . While it has the same sensitivity as the routinely used trypan blue exclusion test, it has a clear advantage over the latter in precluding the necessity to evaluate wet preparations within a limited time, and the use of counterstaining, which allows better distinction between dead and viable cells.
In summary, this study demonstrates that a synthetic PGE2 analogue is able to protect isolated gastric gland cells against indomethacin or ethanol injury under conditions where vascular and extraglandular neural as well as hormonal factors are excluded. This clearly indicates direct protective action of PG on the cells independent of systemic mediation.
